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Abstract
Background: Despite the increasing demand for acupuncture and homoeopathy in Germany, little
is known about the effects of these treatments in routine care. We set up a pragmatic
documentation study in general practice funded within the scope of project launched by a German
health insurer. Patients were followed-up for up to four years.
Methods: The aim of the project was to study the effects and benefits of acupuncture and/or
homoeopathy, and to assess patient satisfaction within a prospective documentation of over 5000
acupuncture and over 900 homoeopathy patients. As data sources, we used the documentation
made available by therapists on every individual visit and a standardised quality-of-life questionnaire
(MOS SF-36); these were complemented by questions concerning the patient's medical history and
by questions on patient satisfaction. The health insurer provided us with data on work absenteeism.
Results: Descriptive analyses of the main outcomes showed benefit of treatment with middle to
large-sized effects for the quality of life questionnaire SF-36 and about 1 point improvement on a
rating scale of effects, given by doctors. Data on the treatment and the patients' and physicians'
background suggests chronically ill patients treated by fairly regular schemes.
Conclusion:  Since the results showed evidence of a subjective benefit for patients from
acupuncture and homoeopathy, this may account for the increase in demand for these treatments
especially when patients are chronically ill and unsatisfied with the conventional treatment given
previously.
Background
In the light of increasing demand for alternative and com-
plementary therapies (CAM) [1,2], discussions about the
effectiveness and effects of these treatments have gained
momentum. This has produced a growing amount of
research, including randomised controlled trials (RCTs).
Research on acupuncture and homoeopathy – two of the
main forms of CAM sought in Germany [3-5], has also
been the subject of systematic reviews [6-8]. However,
there is only scarce research on the effects of acupuncture
and homoeopathy in general practice.
Moreover, most studies only investigate effectiveness in
terms of clinical parameters, such as disease status and
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well-being. Yet, the fact that this does not reflect the whole
picture is evident from theoretical models of successful
treatments and counselling [9] as well as from empirical
findings: Acupuncture and massage, for instance, have
proved to be beneficial if patients seek exactly this sort of
therapy [10]. In addition, most studies use artificial set-
tings, created through strict inclusion and exclusion crite-
ria, or through the application of randomisation to create
a control group. This procedure can lead to highly inter-
nally valid studies with low generalisability. A case can be
made that although RCTs are studies that produce reliable
results if efficacy is the research question, other designs
need to be applied if, for instance, general effects are to be
documented, or patients cannot be randomised, because
they have strong preferences [11,12]. In this case, positive
or negative health effects may be related to the patients'
expectations and to the setting where treatment is applied.
In general practice, therapeutic benefits are triggered by
the purported specific effects of the treatment, by the
patients' and doctors' expectations, and the non-specific
effects of the therapeutic ritual, to name but a few factors.
In Germany, health insurance companies are permitted to
pay for non-conventional therapies such as acupuncture
and homoeopathy within so-called model projects.
According to the law, the projects and hence the treat-
ments given in general practice, have to be evaluated sci-
entifically. Carrying out this type of evaluation in a
prospective documentation gave us the opportunity (i) to
investigate both treatments in real life conditions and (ii)
to study a complex array of therapeutical effects. Our goal
was to document the generic health effects of homoeopa-
thy and acupuncture in general practice in an unselected
patient population seeking the help of qualified doctors.
The study covered documentation of roughly 5000
patients and their treatments. The patients were followed
up over the course of up to four years.
Objectives
The objective of this documentation study was to measure
effects. These were specified in terms of three main out-
come criteria pertaining to three different sources: Quality
of life before and after treatment as reported by patients
(MOS SF-36 German version [13,14]), change of main
symptoms as rated by doctors, and data from the insur-
ance company on work days lost (available for at least 3
years before and after treatment).
A further benefit of this type of documentation approach
lies in the opportunity to gather data regarding the follow-
ing questions:
- What kind of diseases do homoeopathic doctors and
acupuncturists treat?
- Do patients see CAM practitioners on a regular basis or
just once?
- What subjective benefit and satisfaction with treatment
do patients experience?
- How does the general health status of the treated popu-
lation change?
Methods
As a design a prospective documentation was used that
followed the methodology outlined in a predefined and
published protocol [15]. This means that all the patients
insured with the insurance company "Innungskranken-
kasse" (short IKK) who had visited one of the participat-
ing doctors between 1995 and 1998 were eligible for
treatment and hence for inclusion in this study. The IKK
offered these treatments in the three German Länder of
Baden-Wurttemberg, Saxony, and Saxony-Anhalt and
funded this study.
As the study was designed as a real routine-care-assess-
ment the only inclusion criteria were: written informed
consent, ability to read and write German and being
insured with the funding insurance company.
The eligibility criteria of the doctors ensured the quality of
treatment. All of them had to be medical doctors. For
inclusion in the trial phase, they had to send proof of their
qualification to a quality control committee set up by rep-
resentatives of the insurance company and the doctors'
associations. Homoeopaths had to possess the compre-
hensive additional qualification "homoeopathic doctor"
according to standards of the German Homoeopathic
Doctors' Association (Zentralverein homöopathischer Ärzte);
acupuncturists had to have at least 140 hours of training
and hold a so-called A -diploma (certified by an acknowl-
edged acupuncture association).
At the beginning of the study, patients were asked to give
written consent to allow documentation. Consenting
patients were given baseline questionnaires while await-
ing treatment. Post-treatment, acupuncture patients were
asked to fill in a set of questionnaires after the final ses-
sion of a treatment cycle as well as follow-up question-
naires once a year. For homoeopathy – where treatment is
more likely to last several months or years – patients were
asked to fill in questionnaires prior to the treatment and
every 6 months thereafter. The questionnaires after the
treatment had to be answered at home and mailed to the
study centre. This ensured that doctors remained unaware
of the answers given by the patients.BMC Public Health 2004, 4 http://www.biomedcentral.com/1471-2458/4/6
Page 3 of 13
(page number not for citation purposes)
Doctors were asked to document the diagnosis, the appli-
cation of treatment and improvement or deterioration of
the main symptom every time they saw the patient.
At the end of the trial phase, the insurance company sup-
plied information on absence from work.
The following data were recorded:
Patients
Pre-treatment questionnaire on
- socio-demographic variables
- complaints (free text)
- number and type of therapeutic approaches used
- current treatment
- current medication
- reasons for seeking alternative therapy
- health-related quality of life (MOS SF-36)
The post-treatment questionnaire contained the following
items:
- subjective perception of effectiveness
- satisfaction with treatment
- in case of failure or disruption of therapy: reasons
- side effects
- concurrent illnesses during treatment
- health-related quality of life (MOS SF-36)
Follow-up questionnaires repeated the main questions
post-treatment.
Doctors
Initially, a practice profile questionnaire documented
details about training, experience, and techniques nor-
mally applied.
After each session, doctors filled in one sheet concerning
- the type of consultation (first, follow-up, telephone)
- time spent with patient
- up to 3 diagnoses, indicating the main diagnosis
- with each diagnosis: duration and severity of disease,
acute or chronic
- prescriptions (allopathic, homoeopathic, other)
- referrals (specialist, clinic, cure, physio- or
psychotherapy)
- side effects, aggravation, indication of antidotation (only
homoeopathy)
- in the case of acupuncture: acupuncture points and
meridians
- in the case of homoeopathy: key symptoms
Health insurance data
The insurance company provided information for each
patient on:
- work days lost, reasons (diagnoses) for absenteeism
- time insured over the past 8 years
- days in hospital, reasons (diagnoses) for hospital stay
Main outcome criteria
As target criteria we measured
- health related quality of life (SF 36)
- doctors' rating of improvement of main complaint as 7
point symmetrical improvement-deterioration-scale with
anchors "-3 (very much worse)" to "+3 (very much
improved, healed)"
- work absenteeism.
Procedures, data handling and statistics
At the beginning of the study, doctors were informed by
the insurance company and their respective associations.
Interlocutions between the study group and/or the insur-
ance company and the doctors' associations insured coop-
eration. Conferences were held to inform doctors about
the procedures and aims of the study and to ensure their
compliance.
Treatment of data followed the prerequisites for anonym-
ity of patients, and patients' data were neither shown to
their GPs nor to the insurance company. All the data were
sent directly to the study centre and were checked for com-
pleteness. Follow-up questionnaires were sent out to
patients with pre-stamped envelopes by automatisedBMC Public Health 2004, 4 http://www.biomedcentral.com/1471-2458/4/6
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routines and up to two reminders were sent out in case of
no return.
The data were checked for completeness immediately
upon arrival, and reminders or individual letters were
sent, if any material was missing. The data were entered by
hand or using scanning software (Cardiff Teleform), and
plausibility checks were run. If data were missing the fol-
lowing procedures were employed:
Imputation of missing data was only carried out for the
SF-36. We followed the published routines [14] of imput-
ing the personal mean if less than half of the items were
missing. If whole questionnaires were missing, but subse-
quent questionnaires were available, we imputed the val-
ues of the next questionnaire in order to prevent
overestimation over time. This guaranteed a conservative
handling of missing data, but also allowed us to impute at
least half of the missing questionnaires, as the missing
data pattern was rather random than increasing over time.
In a separate study, we checked for the effects of different
missing data interpolation routines and found no differ-
ence between sophisticated regression analytical methods
and interpolation using propensity score and no interpo-
lation [16], which is likely to be an indicator that data are
missing at random. In a telephone interview study, which
is still ongoing, we checked whether non-responders dif-
fered systematically from responders. So far, our experi-
ence favours the hypothesis that non-responders do not
systematically differ from responders in terms of outcome
(data to be published elsewhere).
A comparison of the data given in questionnaires that
were returned too late revealed that there was no signifi-
cant difference in answer patterns. The given descriptive
analysis was therefore carried out for all available data.
Neither work days lost nor the doctor's rating was
imputed when missing, as there was no hint for biased
results. By nature, work days lost are not subject to overes-
timation bias, and by cross-checking the billing forms it
was ensured that the doctor's rating was given for nearly
every patient included in the study.
Data were analysed by Access and SPSS. Due to the
descriptive nature of the study, we relied mainly on
descriptive statistics. In order to quantify effects, we calcu-
lated effect sizes as standardised mean differences accord-
ing to Cohen [17], with the standard deviation at pre-
time-point as standardisation factor.
Because this was an evaluation taking place in general
practice together with some political necessities, the study
had to begin before all data collection and monitoring
routines were in place. This resulted in a somewhat loose
monitoring of data in the first six months of the study,
with many questionnaires being filled in too late, etc. In
all cases of doubt we ran analyses to estimate if there
Table 1: Baseline characteristics
Acupuncture Homoeopathy
Sample size Nmax* = 5116 Nmax* = 515
Gender 53 % women 55 % women
Mean age 42 (SD 14) 30 (SD 18)
Married 71% 48%
Employed 62% 49%
Most frequent self-reported symptoms:
Back pain 31% 14%
Headache 24% 12%
Problems with respiration 14% 9%
Saw doctors for same complaints beforehand: 75% 67%
Of these: seen > 4 other doctors for same 
complaints:
21% 35%
Received acupuncture / homeopathy before+ 20% 20%
Subjective reasons for seeking out this 
treatment+:
"Paid for by insurance company" 69% 73%
"Other treatments unsuccessful" 73% 70%
"Wanted to try" 40% 56%
"Side effects of other treatments" 37% 60%
* depends on the question, some items showed missing data +analysed according to the baseline questionnaire (N = 4487 for acupuncture and N = 
465 for homeopathyBMC Public Health 2004, 4 http://www.biomedcentral.com/1471-2458/4/6
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would be a distortion of results when using the data. We
discarded data suspected of being invalid, always follow-
ing the conservative rule of trying to avoid overestimation
of effects.
In particular, the doctor's rating of success was treated very
conservatively and corrected accordingly to avoid overes-
timation of success. Since this scale was to be gauged to
the last session (change of patient compared to last time
seen), all points were added and standardised on the
number of sessions, which yields a theoretical range from
-3 to +3 with 0 marking the unchanged status. If a doctor
scored "3" more than once a sequence, the following rat-
ings were automatically recoded as unchanged.
Results
Overall, 5292 patients were treated with acupuncture and
933 patients with homoeopathy. Fifty-three patients
received both acupuncture and homoeopathic treatment.
This difference reflects the specialty of participating doc-
tors: Acupuncture was offered by 622 GPs, yet homoeop-
athy by only 52. In addition, for technical and legal
reasons, the evaluation of homoeopathy had only been
incorporated in two of the three German Länder where
the trial phase was launched. These regions of East Ger-
many do not have a long-standing tradition of homoeop-
athy and therefore do not have many practising
homoeopaths.
Within the trial phase, 12% of the acupuncture patients
attended booster sessions or reappeared for follow-up ses-
sions with the same treatment, compared with 10% of the
homoeopathy patients. Return rates corresponded to 90%
of all pre-questionnaires. Post treatment, 60% of the
patients returned the questionnaire within an appropriate
time frame. This figure dropped slightly to 50% in the fol-
low-up period. This is still an acceptable return rate, given
the fact that this was 24 months after therapy and that the
questionnaires were sent by mail.
Results are presented separately for acupuncture and
homoeopathy in table 1.
Doctors
Some data describing the practice size is given in Table 2.
It is evident that doctors not only applied the treatment
options they were accredited for in the trial phase, but to
a great extent also other allopathic and CAM treatments.
Acupuncture
More than 5000 patients were treated with acupuncture.
Around 4400 patients participated in the study and filled
in the baseline questionnaire. Sample size is smaller than
the overall number of patients due to missing consent or
failure to reply in time. The mean age was 42 years, 71%
were married and 62% employed (Table 1). The low
employment rate is due to the fact that also family mem-
bers, who often are housewives or students were entitled
to the treatment.
In response to a free text question about complaints at
baseline, acupuncture patients most frequently reported
the following symptoms: Back pain (31%), headache
(24%), and problems with the respiratory system (14%).
Moreover, 75% of the patients reported having had con-
ventional treatment for these symptoms and 20% had had
acupuncture before. The main reasons why patients
sought acupuncture were (i) the low perceived
effectiveness of other treatments (73%) and (ii) payment
by the insurance company (69%).
The main diagnoses documented by the GPs according to
the ICD-system were diseases of the musculoskeletal system
and connective tissue (52%, mainly dorsopathies), diseases
of the nervous system and sensory organs (19%, predomi-
nantly migraine) and diseases of the respiratory system (18%,
see Figure 1).
Table 2: Descriptors doctors' sample
Acupuncture Homoeopathy
Patients seen quarterly* min = 4/ max = 3000 mean = 1060/ SD = 556 min = 60/ max = 1500 mean = 834/ SD = 428
Time since start of practicing (in years) min = 1/ max = 39 mean = 8/ SD = 5 min = 3/ max = 35 mean = 13/ SD = 10
Other treatments used
Allopathy 95% yes 88% Yes
Acupuncture/homoeopathy 36% yes 69% yes
Phytomedicine 56% yes 63% yes
Anthroposophical medicine 6% yes 6% yes
Neural therapy 63% yes 50% yes
* doctors may have understood this question as referring to the trial phase, or to their practice size in generalBMC Public Health 2004, 4 http://www.biomedcentral.com/1471-2458/4/6
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It is noteworthy that 82% of the conditions appeared to
be chronic (lasting longer than 6 months) and 36% were
labelled by the doctors as being severe.
When asked after treatment whether and how their com-
plaints had changed, the following picture emerged: 36%
of all acupuncture patients felt very much better and 49%
felt somewhat better, 13% thought their symptoms were
unchanged, and only 1% reported a deterioration of
symptoms (see upper half of table 3).
Therapeutic effects as rated by the GPs showed a 0.9 (SD
= 0.5) improvement of on a 7-point scale (accumulated
and standardised ratings in the range between "-3 = much
worse" and "+3 = much better" for change from session to
session).
As mentioned above, one main outcome criterion was
quality of life as assessed by the SF-36.
Table 4 and figure 2 show that all scales revealed substan-
tial improvement over the first 6 months after treatment
and that this effect remained more or less stable over the
following years. It should be noted that pre-measurement
and post-measurement reflects the status before and after
the first treatment, as this is the state patients were in at
the beginning of the trial phase. The follow-up measure-
ments were sent out to patients at the time points 12
months after treatment and then every 12 months. It is
noteworthy that the ratings refer to the last four weeks,
irrespectively of additional treatments within the preced-
ing weeks and months. As indicated above, about 16% of
the patients reappeared for the same treatment within the
trial phase.
The effect sizes show middle-sized effects, with best effects
for the bodily pain scale and the physical role scale.
Regarding work absenteeism, the insurance company pro-
vided us with data on work days lost over 16 years, includ-
ing up to 9 years before treatment and up to 7 years since
treatment. Figure 3 gives the results of work days lost from
6 years before treatment up to 5 years after treatment. As
can be seen, there is a steady incline in days until the year
the first treatment took place followed by a continuous
decline. The Friedman test of median ranks also showed
the significant incline and decline. Records of absentee-
ism rather than days lost show an equivalent increase and
decrease (data not shown). Figure 3 also gives the results
for all patients treated. The lower three lines of figure 3
give the results for patients treated in 1997 (see 'S-1997'
for the sample size and 'Smean' for mean values of the
subsample). These results can be compared with a
reference population consisting of all patients insured
with the same health insurer in the same part of Germany
(see lowest line in figure 3).
While the reference population remained more or less the
same, the mean values of the subsample rise to twice the
work days lost in the 2 years prior to treatment, but return
to normal within 2 to 3 years.
Homoeopathy
Some 1000 patients received homoeopathic treatment.
The patients participating in the study had a mean age of
30 years, 55% were female, 47% were married and 49%
were employed (Table 1).
Diagnoses according to the documentation of GPs  (acupuncture) Figure 1
Diagnoses according to the documentation of GPs 
(acupuncture)
Table 3: Subjective change after treatment
Acupuncture
Change of complaints
„Better" 36%
„somewhat better" 49%
„Unchanged" 13%
„Worse" 1%
Homoeopathy
Change of complaints
„Better" 39%
„somewhat better" 38%
„Unchanged" 17%
„Worse" 2%BMC Public Health 2004, 4 http://www.biomedcentral.com/1471-2458/4/6
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The most frequently self-reported symptoms and com-
plaints concerned the respiratory system (16%) and skin
problems (19%). Less frequently, back pain (7%) and
headaches (10%) were reported. Of the homoeopathy
patients, 65% stated that they had received conventional
treatment and 29% had visited more than 4 doctors in
advance. 19% of the patients had had homoeopathic
treatment for the reported symptoms before.
Treatment motivation was given as being, (i) the low per-
ceived effectiveness of other treatments (70%) and (ii)
payment by the insurance company (73%). Less promi-
nent reasons were (iii) the side effects of other treatments
(60%) and (iv) the desire to be treated with homoeopathy
(56%) (also Table 1).
The main ICD diagnoses given by the GPs were diseases of
the skin and subcutaneous tissue (21%, mainly dermatitis)
and diseases of the respiratory system (19%, see Figure 4).
Other diagnoses did not exceed 15%. Similarly to the case
of acupuncture patients, doctors diagnosed 76% of the
conditions as being chronic (lasting longer than 6
months) and 30% as being severe.
After treatment, the patients were asked to rate whether
and how complaints had changed. Over follow-up time,
39% of homoeopathy patients felt very much better and
38% felt somewhat better, 17% thought the symptoms
were unchanged, and only 2% reported a deterioration of
symptoms (see bottom half of table 3).
Therapeutic effects as rated by the GPs showed a 0.95
improvement (SD = 0.7) on a 7-point rating scale (accu-
mulated over all the homoeopathic sessions).
Results regarding quality of life as assessed by the SF-36
are presented in Table 4 and Figure 5. All scales revealed
substantial improvement over the first 6 months after
treatment and this effect remained more or less stable over
the following years.
Work days lost show an incline of mean values before
treatment, followed by a decline after treatment. This is
not reflected by the median values, but the Friedman test
of mean ranks of medians also revealed a significant
increase and decrease of days of absenteeism (see Figure
6). This is also true for the records of absenteeism (data
not shown).
Table 4: Quality of life pre and post treatment (SF-36 scales)
Acupuncture Homoeopathy
Baseline Post Measurement Effect sizes (d)$ Baseline 6 months post Effect sizes (d$)
Physical Functioning (PF) N = 4029
mean = 70
SD = 26
N = 3070
mean = 77
SD = 24
d = .28 N = 359
mean = 84
SD = 21
N = 301
mean = 89
SD = 18
d = .24
Role Physical (RP) N = 3950 
mean = 44 
SD = 41
N = 3019 
mean = 64# 
SD = 41
d = .49 N = 359 
mean = 62 
SD = 41
N = 301 
mean = 83# 
SD = 32
d = .51
Bodily Pain (BP) N = 4220 
mean = 36 
SD = 26
N = 3147 
mean = 49# 
SD = 27
d = .45 N = 373 
mean = 57 
SD = 31
N = 312 
mean = 73# 
SD = 30
d = .52
Gen. Health Perception (GH) N = 4094 
mean = 54 
SD = 20
N = 3075 
mean = 59 
SD = 19
d = .26 N = 368 
mean = 53 
SD = 19
N = 305 
mean = 68# 
SD = 20
d = .79
Vitality (VT) N = 4214 
mean = 46 
SD = 19
N = 3140 
mean = 54 
SD = 19
d = .36 N = 376 
mean = 48 
SD = 18
N = 309 
mean = 61# 
SD = 19
d = .72
Social Functioning (SF) N = 4293 
mean = 70 
SD = 25
N = 3194 
mean = 79# 
SD = 22
d = .37 N = 378 
mean = 72 
SD = 25
N = 314 
mean = 84# 
SD = 20
d = .48
Role Emotional (RE) N = 3875 
mean = 68 
SD = 41
N = 2977 
mean = 78# 
SD = 37
d = .23 N = 356 
mean = 73 
SD = 39
N = 298 
mean = 87# 
SD = 30
d = .36
Mental Health (MH) N = 4170 
mean = 60 
SD = 19
N = 3117 
mean = 67 
SD = 18
d = .31 N = 376 
mean = 59 
SD = 18
N = 312 
mean = 69# 
SD = 16
d = .56
# clinically relevant (>=10 % improvement) $ d means effect size according to Cohen, with (MEANpost - MEANbaseline)/SDbaseline, d < 0.3 defined as 
small, d < 0.8 is assumed as being middle-sized, d > 0.8 is regarded as high [17]BMC Public Health 2004, 4 http://www.biomedcentral.com/1471-2458/4/6
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Compared to the reference population, the patients
included in the trial phase showed less work absenteeism
prior to treatment. This could have been assumed as work
absenteeism is mostly due to back pain and accidents (for
long periods), but not migraine and allergic rhinitis.
Nevertheless, around the year of treatment work absentee-
ism exceeds the mean values of the reference population,
but drops to a lower level compared to reference means.
Adverse events
Both patients and doctors were asked to report adverse
reactions to the treatment (see Table 5). The highest rate
was given by homeoepathy patients (7%). One has to
bear in mind that homoeopathy sometimes produces
symptoms of initial aggravation, when therapy is going to
work well. 5% of the acupuncture patients felt some
adverse reactions to the treatment. Further investigation
revealed that these were minor reactions like needle
sensation.
Discussion
This prospective observational documentation study was
designed to bridge the gap between clinical studies in the
tradition of pharmaceutical research in CAM and every-
day, real life practice. It also gives an insight into the eve-
ryday practice of acupuncture and homoeopathy deliv-
ered by general practitioners or CAM specialists within the
insurance system.
The results show evidence of subjective benefits in all
three main outcome criteria. The doctors' ratings of the
change of complaints showed significant improvement of
complaints over the course of treatment. Taking standard
deviations into account, it is apparent that this is not due
to overestimation. The improvement under acupuncture
treatment was about 2 SDs and the improvement under
homoeopathy (which is an even more comprehensive
treatment) was a little lower. This overall improvement
was vindicated by quality-of-life data. Effect sizes from pre
to post-treatment showed middle to large effects. The
effect sizes of homoeopathy are even greater. This might
Quality of life during follow-up (acupuncture) Figure 2
Quality of life during follow-up (acupuncture)
35
45
55
65
75
PF 70 77 77 75 74 75
RP 44 64 64 62 61 59
BP 36 49 50 49 48 49
GH 54 59 58 58 58 59
VT 46 54 53 53 53 53
SF 70 79 78 78 77 77
RE 68 78 77 76 75 73
MH 60 67 66 65 66 64
pre,        
Nmax: 4029
post,         
Nmax: 3950
12 months, 
Nmax: 2970
24 months, 
Nmax: 2295
36 months, 
Nmax: 1090
48 months, 
Nmax: 121
max=100%
min=0%
(25) (26) (26) (27)
(42) (43)
(29)
(21)
(19)
(24)
(38)
(19)
(28) (28)
(21)
(19)
(24)
(39)
(19)
(43) (45)
(29)
(21)
(20)
(41)
(23)
(20)
(20)
(24)
(40)
(19) (19)
follow-up
(24)
(41)
(27)
(19)
(19)
(22)
(37)
(18)
(26)#
(41)
(26)
(20)
(19)
(25)
(41)
(19)
*
# represents percent on the 0 to 100-scale; mean scores (SD) given
PF= Physical Functioning
RP=Role Phsysical
BP=Bodily Pain
GH= General Health Perception
VT=Vitality
SF=Social Functioning
RE=Role Emotional
MH=Mental HealthBMC Public Health 2004, 4 http://www.biomedcentral.com/1471-2458/4/6
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be because a longer period was observed and the therapy
seems to result in a significant improvement of the per-
ception of well-being (general health, vitality) and role
scales.
Despite being very satisfied with the treatment and expe-
riencing a clear subjective benefit, only about 16% of the
patients sought booster treatments. Follow-up
questionnaires from a subsidiary study part, which have
not as yet been fully analysed show that about half the
patients did not go to booster sessions simply because
they felt they had been cured. This is even more astonish-
ing because their physicians labelled their diagnoses as
chronic and severe. Nevertheless, it seems to fit the general
notion of improved subjective health and well-being of
the patients seen in the stable course of the SF-36-scales.
Work days lost before/after treatment (acupuncture patients) Figure 3
Work days lost before/after treatment (acupuncture patients)
year minus 3: 3,30
year minus 2: 3,90
year minus 1: 4,35
year zero: 4,55
year plus 1: 4,25
year plus 2: 4,14
year plus 3: 3,51
Chi2:476,119
df: 6
Sign: .000
Friedman-Test:
mean ranksBMC Public Health 2004, 4 http://www.biomedcentral.com/1471-2458/4/6
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However, some problems were encountered in this long-
term documentation study. At the beginning of the study,
persistent efforts were made to set up a control group of
conventional treatment. We also tried to obtain data on
the insurance company's cost records. Unfortunately,
both efforts failed. This was partly due to German data
protection laws and partly to the lack of interest among
conventional practitioners, who would only have
cooperated on reimbursement, which is not a legally via-
ble option for publicly funded insurance companies. This
is particularly unfortunate because being dissatisfied with
other therapies a great number of patients had come to see
the CAM therapists. Without a concurrent control group it
is difficult to put the data into context, and conclusions
therefore have to be made using indirect methods. What
we can derive from our data is that in general patients are
very satisfied, not only with the treatment, but also with
the effects of the treatment. This satisfaction is not only
seen in self-report items, but is also reflected in the stand-
ardised and well-validated scale SF-36, which is known to
be very robust and does not easily overestimate change.
Effect sizes and numerical differences show that the expe-
rienced effects were sizeable, clinically meaningful [18],
and stable over time.
Diagnoses according to GP's documentation of  (homoeopathy) Figure 4
Diagnoses according to GP's documentation of 
(homoeopathy)
Quality of life during follow-up (homoeopathy) Figure 5
Quality of life during follow-up (homoeopathy)
45
55
65
75
85
PF 84 89 90 89 88 89
RP 62 83 84 84 83 80
BP 57 73 71 72 72 68
GH 53 68 67 68 68 67
VT 48 61 61 59 59 60
SF 72 84 85 84 84 84
RE 73 87 86 86 86 85
MH 59 69 69 68 68 68
pre,          
Nmax: 359
post,         
Nmax: 301
12 months, 
Nmax: 270
18 months, 
Nmax: 240
24 months, 
Nmax: 188
30 months, 
Nmax: 129
max=100%
min=0%
(25) (26) (26) (27)
(42) (43)
(29)
(21)
(19)
(24)
(38)
(19)
(28) (28)
(21)
(19)
(24)
(39)
(19)
(43) (45)
(29)
(21)
(20)
(41)
(23)
(20)
(20)
(24)
(40)
(19) (19)
follow-up
(18)
(32)
(30)
(20)
(19)
(20)
(30)
(16)
(21)#
(41)
(31)
(19)
(18)
(25)
(39)
(18)
# mean scores and SD’s (0-100 percent scale)
PF= Physical Functioning
RP=Role Phsysical
BP=Bodily Pain
GH= General Health  Perception
VT=Vitality
SF=Social Functioning
RE=Role Emotional
MH=Mental HealthBMC Public Health 2004, 4 http://www.biomedcentral.com/1471-2458/4/6
Page 11 of 13
(page number not for citation purposes)
One might argue that in a study like ours there are always
a large number of non-responders due to the long obser-
vation time, and because patients do not understand why
they should fill in questionnaires regarding treatment
they had years ago. While our return rate was not bad, it
was far from perfect. We achieved acceptable return rates
of roughly 90% for the pre-treatment questionnaires and
50% for the follow-up questionnaires. Interpolating the
missing data points with intricate routines derived from
regression analytical methods did not change the picture,
indicating that data were missing at random. We are in the
process of conducting a subsidiary study with telephone
interviews to find out if and how non-responders differ
from responders. A first study to that effect employing tel-
ephone interviews with randomly selected non-respond-
ers showed that they did not differ in follow-up
parameters from responders in that sample. Thus, we are
confident that our data do not reflect a response bias of
particularly healthy or diseased patients, but document a
fair average of the whole population.
Work days lost before/after treatment (homoeopathy patients) Figure 6
Work days lost before/after treatment (homoeopathy patients)
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Is it possible that the patients would have experienced the
same pattern of improvement if no therapy or conven-
tional therapy had been applied? This seems rather
unlikely, since the majority of patients sought help for
long standing problems, which were resistant to conven-
tional treatments, and thus by default unlikely to regress
back to normal. The documented improvement is also
unlikely to be due to concurrent conventional or other
treatments. The documented usage of other medical
treatments pertained rather to routine visits and decreased
slightly. This is also true for the intake of painkillers and
other pills.
The data on work days lost show that the patients go back
to normal after treatment. Mean values peak around the
year when treatment was applied. Since these data are
skewed toward zero, the Friedman-Test of significance of
mean ranks was applied and resulted in highly significant
orders of median ranks before and after treatment. Com-
pared to a reference population, acupuncture patients
have much higher rates of absenteeism, whereas homoe-
opathy patients show only higher rates for the time close
to the treatment. This underlines the validity of the data
on work days lost as patients with back pain are known to
produce constant and high rates of absenteeism. Since the
data is highly skewed and the regression may be due to
outliers, we also analysed the proportion of patients with
0 days and the proportion of outliers (mean values plus 1
SD). For acupuncture the number of patients with 0 days
was 71% for a period of 2 years before treatment, and 58%
for the year of treatment. The rate returned to 64% 2 years
post treatment. 6% were outliers 2 years prior to
treatment, 7% when treatment was applied and only 4%
had days lost at work outside the given range for 2 years
after the first acupuncture cycle.
A very similar picture emerged for homoeopathy: 59%
had no work days lost 2 years before the first consultation
and 7% lay outside the range. In the year of treatment,
42% showed no days lost to work, but 9% were outliers.
2 years after treatment, 8% still lay outside the given
range. The higher rate of outliers and the lower number of
patients with no days absent from work shows that regres-
sion to the mean is not a very likely explanation for the
decline in work days lost after treatment.
The costs of the alternative treatments offered within the
test phase are clear-cut: Neither homoeopaths nor acu-
puncturists employ fancy technical products. They do not
order a large number of diagnostics, and the number of
sessions taken to achieve the results are modest: On aver-
age, 10 acupuncture and 2 to 3 homoeopathy sessions
were necessary to achieve the effects with stability over
four years, which translates to a rough estimate of €300
per patient, with no hidden costs for expensive drugs. To
treat a migraine patient suffering 2 attacks a month over
the course of one year, using an effective triptane would
cost at least the same in one year, taking only the drug
costs into account and without including the cost of visits
to the doctor and the cost of diagnostics. Thus, here we
have a potential for cost-saving warranting further and
more intricate exploration.
Conclusions
The types of homoeopathy or acupuncture we studied
were fairly mundane. While we also had some experi-
enced doctors in our sample, most of the doctors in the
study had undergone training 5 to 10 years previously.
Thus, we documented what subjective benefit patients can
expect from an average homoeopathic doctor or acupunc-
turist in Germany and probably elsewhere. Even so, the
recommendation based on the summary of our data
would be that both homoeopathy and acupuncture seem
to be effective practices that satisfy patients, and help the
majority to a sufficient degree. Our study is a very first hint
in that direction and provides material for further and
more in-depth scrutiny. Future studies should place
emphasis on careful documentation of the cost and effects
of conventional treatment as compared to CAM
treatment.
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Table 5: Adverse events
Acupuncture Homoeopathy
Patients rating N = 3052 N = 852
Yes 4,8% 7,4%
No 94,0% 89,2%
Doctors' rating N = 5435 treatment 
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N = 553 treatment 
sessions
Yes 0,8% 2,2%
No 56,9% 16,3
Missing Data* 42,2% 81,6%
* highly likely that item was not completed when no adverse event 
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